We provide you with 20 years of free, institutional-grade data for ZTS stock, allowing you to gain comprehensive visibility into the fundamentals of the company. This in-depth information is essential for making informed investment decisions and understanding the financial health and performance of ZTS. Explore the full financial landscape of ZTS stock.
Total insider purchase within 3 month on this page: $886,366
Total insider selling within 3 month on this page: -$8,622
| Name | Action | Shares | Avg Price | Amount | Reported Date |
|---|---|---|---|---|---|
| Stetter Mark | Derivatives Exercise | 1,572 | 2026-05-26 | ||
| Stetter Mark | RSU | 1,572 | 2026-05-26 | ||
| PARENT LOUISE M | Derivatives Exercise | 12,130 | 2026-05-21 | ||
| PARENT LOUISE M | RSU | 1,944 | 2026-05-21 | ||
| Bisaro Paul | Open Market Purchase | 2,000 | $75.88 | 2026-05-13 | |
| DAMELIO FRANK A | Open Market Purchase | 6,650 | $75.39 | 2026-05-13 | |
| MCCALLISTER MICHAEL B | Open Market Purchase | 3,000 | $77.76 | 2026-05-12 | |
| Esch Kevin | Sale | -75 | $114.97 | $8,623 | 2026-05-01 |
| Esch Kevin | Derivatives Exercise | 259 | 2026-05-01 | ||
| Esch Kevin | RSU | 259 | 2026-05-01 | ||
| Sarbaugh Keith | Sale | -524 | $118.21 | $61,942 | 2026-04-01 |
| Sarbaugh Keith | Derivatives Exercise | 1,528 | 2026-04-01 | ||
| Sarbaugh Keith | RSU | 1,528 | 2026-04-01 | ||
| MCCALLISTER MICHAEL B | Derivatives Exercise | 1,619 | 2026-02-23 | ||
| MCCALLISTER MICHAEL B | RSU | 1,619 | 2026-02-23 | ||
| FULLER JULIE | Sale | -269 | $146.32 | $39,360 | 2025-10-01 |
| FULLER JULIE | Derivatives Exercise | 784 | 2025-10-01 | ||
| FULLER JULIE | RSU | 784 | 2025-10-01 | ||
| Broadhurst Vanessa | Derivatives Exercise | 1,412 | 2025-07-28 | ||
| Broadhurst Vanessa | RSU | 1,412 | 2025-07-28 | ||
| Lagano Roxanne | Sale | -652 | $170 | $110,840 | 2025-06-04 |
| SCULLY ROBERT W | Derivatives Exercise | 17,535 | 2025-05-23 | ||
| SCULLY ROBERT W | RSU | 1,601 | 2025-05-23 | ||
| Hattersley Gavin | Derivatives Exercise | 1,451 | 2025-04-02 | ||
| Hattersley Gavin | RSU | 1,451 | 2025-04-02 | ||
| Sarbaugh Keith | Sale | -516 | $164.65 | $84,959 | 2025-04-01 |
| Sarbaugh Keith | Derivatives Exercise | 1,506 | 2025-04-01 | ||
| Sarbaugh Keith | RSU | 1,506 | 2025-04-01 | ||
| Lagano Roxanne | Sale | -326 | $170 | $55,420 | 2025-03-11 |
| Reed Willie M | Sale | -1,210 | $166.14 | $201,029 | 2025-03-11 |
| PECK KRISTIN C | Sale | -382 | $156.68 | $59,852 | 2025-02-20 |
| PECK KRISTIN C | Derivatives Exercise | 382 | 2025-02-20 | ||
| Brannan Jamie | Sale | -313 | $171.43 | $53,658 | 2025-02-11 |
| Brannan Jamie | Derivatives Exercise | 663 | 2025-02-11 | ||
| Brannan Jamie | RSU | 663 | 2025-02-11 | ||
| Joseph Wetteny | Sale | -1,510 | $171.43 | $258,859 | 2025-02-11 |
| Joseph Wetteny | Derivatives Exercise | 4,325 | 2025-02-11 | ||
| Joseph Wetteny | RSU | 4,325 | 2025-02-11 | ||
| Ferran Astorga Jeannette | Sale | -277 | $171.43 | $47,486 | 2025-02-11 |
| Ferran Astorga Jeannette | Derivatives Exercise | 691 | 2025-02-11 | ||
| Ferran Astorga Jeannette | RSU | 691 | 2025-02-11 | ||
| Norden Gregory | Derivatives Exercise | 1,225 | 2025-02-11 | ||
| Norden Gregory | RSU | 1,225 | 2025-02-11 | ||
| PARENT LOUISE M | Derivatives Exercise | 1,225 | 2025-02-11 | ||
| PARENT LOUISE M | RSU | 1,225 | 2025-02-11 | ||
| Sanjay Khosla | RSU | 1,225 | 2025-02-11 | ||
| DAMELIO FRANK A | RSU | 1,225 | 2025-02-11 | ||
| Leatherberry Antoinette Renee | Derivatives Exercise | 1,225 | 2025-02-11 | ||
| Leatherberry Antoinette Renee | RSU | 1,225 | 2025-02-11 | ||
| PECK KRISTIN C | Sale | -9,197 | $171.43 | $1,576,642 | 2025-02-11 |
| PECK KRISTIN C | Derivatives Exercise | 20,433 | 2025-02-11 | ||
| PECK KRISTIN C | RSU | 20,433 | 2025-02-11 | ||
| Reed Willie M | Derivatives Exercise | 1,225 | 2025-02-11 | ||
| Reed Willie M | RSU | 1,225 | 2025-02-11 | ||
| Lagano Roxanne | Sale | -1,016 | $171.43 | $174,173 | 2025-02-11 |
| Lagano Roxanne | Derivatives Exercise | 2,001 | 2025-02-11 | ||
| Lagano Roxanne | RSU | 2,001 | 2025-02-11 | ||
| MCCALLISTER MICHAEL B | Derivatives Exercise | 1,225 | 2025-02-11 | ||
| MCCALLISTER MICHAEL B | RSU | 1,225 | 2025-02-11 |
The information provided in this report about ZTS stock is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
Zoetis Inc(NYSE:ZTS) 
Zoetis Inc. discovers, develops, manufactures, and commercializes animal health medicines, vaccines, and diagnostic products in the United States and internationally. It commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep; and compan...
Website: http://www.zoetis.com
Founded: 1952
Full Time Employees: 10,600
Sector: Healthcare
Industry: Drug Manufacturers-Specialty & Generic